US HB3443 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on June 24 2019 - 25% progression, died in chamber
Action: 2019-07-24 - Sponsor introductory remarks on measure. (CR E971)
Text: Latest bill text (Introduced) [PDF]

Summary

To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019

Sponsors


History

DateChamberAction
2019-07-24HouseSponsor introductory remarks on measure. (CR E971)
2019-06-25HouseReferred to the Subcommittee on Health.
2019-06-24HouseReferred to the House Committee on Energy and Commerce.
2019-06-24HouseIntroduced in House

Same As/Similar To

HB269 (Related) 2019-01-10 - Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.
SB2740 (Related) 2019-12-14 - Referred to the Subcommittee on Health.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
HB748 (Related) 2020-07-23 - Committee on Small Business and Entrepreneurship. Hearings held.

Subjects


US Congress State Sources


Bill Comments

feedback